Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Motor Cortex Excitability and BDNF Levels in Chronic Musculoskeletal Pain According to Structural Pathology.

Caumo W, Deitos A, Carvalho S, Leite J, Carvalho F, Dussán-Sarria JA, Lopes Tarragó Mda G, Souza A, Torres IL, Fregni F.

Front Hum Neurosci. 2016 Jul 15;10:357. doi: 10.3389/fnhum.2016.00357. eCollection 2016.

2.

Brain-Derived Neurotrophic Factor and Antidepressive Effect of Electroconvulsive Therapy: Systematic Review and Meta-Analyses of the Preclinical and Clinical Literature.

Polyakova M, Schroeter ML, Elzinga BM, Holiga S, Schoenknecht P, de Kloet ER, Molendijk ML.

PLoS One. 2015 Nov 3;10(11):e0141564. doi: 10.1371/journal.pone.0141564. eCollection 2015. Review.

3.

Immune and neurotrophin stimulation by electroconvulsive therapy: is some inflammation needed after all?

van Buel EM, Patas K, Peters M, Bosker FJ, Eisel UL, Klein HC.

Transl Psychiatry. 2015 Jul 28;5:e609. doi: 10.1038/tp.2015.100. Review.

4.
5.

BDNF plasma levels after antidepressant treatment with sertraline and transcranial direct current stimulation: results from a factorial, randomized, sham-controlled trial.

Brunoni AR, Machado-Vieira R, Zarate CA Jr, Vieira EL, Vanderhasselt MA, Nitsche MA, Valiengo L, Benseñor IM, Lotufo PA, Gattaz WF, Teixeira AL.

Eur Neuropsychopharmacol. 2014 Jul;24(7):1144-51. doi: 10.1016/j.euroneuro.2014.03.006. Epub 2014 Mar 27.

6.

The Role of the Val66Met Polymorphism of the Brain Derived Neurotrophic Factor Gene in Coping Strategies Relevant to Depressive Symptoms.

Caldwell W, McInnis OA, McQuaid RJ, Liu G, Stead JD, Anisman H, Hayley S.

PLoS One. 2013 Jun 18;8(6):e65547. doi: 10.1371/journal.pone.0065547. Print 2013.

7.

Neuromodulation therapies and treatment-resistant depression.

Al-Harbi KS, Qureshi NA.

Med Devices (Auckl). 2012;5:53-65. doi: 10.2147/MDER.S33198. Epub 2012 Jul 13.

8.

Dysfunction in fatty acid amide hydrolase is associated with depressive-like behavior in Wistar Kyoto rats.

Vinod KY, Xie S, Psychoyos D, Hungund BL, Cooper TB, Tejani-Butt SM.

PLoS One. 2012;7(5):e36743. doi: 10.1371/journal.pone.0036743. Epub 2012 May 14.

9.

Effects of electroconvulsive therapy and repetitive transcranial magnetic stimulation on serum brain-derived neurotrophic factor levels in patients with depression.

Gedge L, Beaudoin A, Lazowski L, du Toit R, Jokic R, Milev R.

Front Psychiatry. 2012 Feb 24;3:12. doi: 10.3389/fpsyt.2012.00012. eCollection 2012.

10.

Developing biomarkers for methamphetamine addiction.

Mendelson J, Baggott MJ, Flower K, Galloway G.

Curr Neuropharmacol. 2011 Mar;9(1):100-3. doi: 10.2174/157015911795017128.

11.

Non-invasive brain stimulation approaches to fibromyalgia pain.

Short B, Borckardt JJ, George M, Beam W, Reeves ST.

J Pain Manag. 2009 Jan 1;2(3):259-276.

12.

Functional biomarkers of depression: diagnosis, treatment, and pathophysiology.

Schmidt HD, Shelton RC, Duman RS.

Neuropsychopharmacology. 2011 Nov;36(12):2375-94. doi: 10.1038/npp.2011.151. Epub 2011 Aug 3. Review.

13.

Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models.

Schmidt HD, Duman RS.

Neuropsychopharmacology. 2010 Nov;35(12):2378-91. doi: 10.1038/npp.2010.114. Epub 2010 Aug 4. Erratum in: Neuropsychopharmacology. 2011 Jan;36(2):550.

Supplemental Content

Support Center